Akt Inhibitor V Triciribine CAS: 35943-35-2

CAS NO: 35943-35-2
Akt Inhibitor V Triciribine
Chemical Name: API-2
Molecular Formula: C13H16N6O4
Formula Weight: 320.3
CAS No.: 35943-35-2
Description Review
Description

Akt inhibitor V triciribine CAS: 35943-35-2 is a small molecule inhibitor that targets the Akt signaling pathway. This pathway plays a key role in regulating cell survival, proliferation, and growth, making it an attractive target for cancer therapy.

Chemical Name:

Akt inhibitor V triciribine is also known as NSC154020 and TCN.

Molecular Formula:

The molecular formula of Akt inhibitor V triciribine is C13H16N6O4S.

Formula Weight:

The formula weight of Akt inhibitor V triciribine is 360.37 g/mol.

CAS No:

The CAS number of Akt inhibitor V triciribine is 35943-35-2.

Top Ten Keywords from Google and Synonyms:

  1. Cancer Treatment
  2. Akt Signaling Pathway Inhibitor
  3. Apoptosis Inducer
  4. Tumor Suppressant
  5. Cell Proliferation Inhibitor
  6. Anti-Cancer Drug
  7. Chemotherapy Agent
  8. Protein Kinase Inhibitor
  9. Cell Growth Inhibitor
  10. Akt Inhibitor TCN

Health Benefits of Akt Inhibitor V Triciribine:

Akt inhibitor V triciribine has shown potential health benefits due to its ability to inhibit the Akt signaling pathway. Some of the potential benefits of Akt inhibitor V triciribine include:

  1. Cancer Treatment: Akt inhibitor V triciribine is being studied as a potential cancer treatment due to its ability to inhibit cell survival and proliferation.

Potential Effects:

Akt inhibitor V triciribine can produce a range of effects depending on the dosage and individual response. Some of the potential effects of Akt inhibitor V triciribine include:

  1. Inhibition of Cell Survival: Akt inhibitor V triciribine can inhibit cell survival by blocking the Akt signaling pathway.

Product Mechanism:

Akt inhibitor V triciribine works by inhibiting the Akt signaling pathway, which plays a key role in regulating cell survival, proliferation, and growth. By blocking this pathway, Akt inhibitor V triciribine can induce apoptosis, or programmed cell death, and inhibit tumor growth.

Safety:

Akt inhibitor V triciribine can be safe when used appropriately and under medical supervision. However, it can cause adverse effects if misused or abused. Some of the potential side effects of Akt inhibitor V triciribine include:

  1. Gastrointestinal Disturbances: Akt inhibitor V triciribine may cause gastrointestinal disturbances such as nausea and vomiting.

  2. Liver Toxicity: Akt inhibitor V triciribine may cause liver toxicity in some individuals.

Dosing Information:

The appropriate dose of Akt inhibitor V triciribine depends on several factors such as age, weight, and health status. It is essential to follow dosing instructions carefully and only use Akt inhibitor V triciribine under medical supervision.

Conclusion:

Akt inhibitor V triciribine is a small molecule inhibitor that targets the Akt signaling pathway. It has shown potential as a cancer treatment due to its ability to inhibit cell survival and proliferation. While Akt inhibitor V triciribine may provide some health benefits, it should only be used under medical supervision and with caution due to its potential side effects. Additionally, more research is needed to fully understand its safety and efficacy in humans

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code